Evidence map›Paper›PMID 36321775›Full record

ArticleOncology reports2022

Kidney in VHL disease: Early clear cell proliferation occurs in the distal tubular system.

Nayef S Al-Gharaibeh, Constance J Temm, Sharon B Shively, Alexander O Vortmeyer

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nayef S Al-GharaibehDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Constance J TemmDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Sharon B ShivelySurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.
Alexander O VortmeyerDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USNational Institute of Neurological Disorders and Stroke · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal clear cell carcinoma commonly occurs in patients with von Hippel‑Lindau disease (VHL). Kidneys of VHL disease patients (VHL kidneys) contain an abundance of independent clear cell proliferation events that have been hypothesized to represent precursor structures of clear cell carcinoma. In the present study, it was tried to identify the site of origin of clear cell proliferation, and the immunophenotype of clear cells. Using 3D histological tracking, the topographic origin of microscopic clear cell proliferation was investigated by identification of informative structures of interest and immunohistochemical staining for cluster of differentiation 10 (CD10) and cytokeratin 7 (CK7) in consecutive serial sections. In addition, the CD10/CK7 immunophenotype of proliferating clear cells was evaluated. Clear cell proliferation uniformly occurred in the distal tubular system. Some clear cell proliferation, however, revealed proximal tubule immunophenotype. It was concluded that early proliferation of VHL‑deficient clear cells occurs in the distal tubular system. Despite the association with the distal tubular system, the immunohistochemical profile of early clear cell proliferation may be inconsistent with its distal tubular origin.

Indexed as

Carcinoma, Renal CellKidney Neoplasmsvon Hippel-Lindau DiseaseCell ProliferationHumansKeratin-7KidneyVon Hippel-Lindau Tumor Suppressor ProteinKeratin-7VHL protein, humanVon Hippel-Lindau Tumor Suppressor Proteincarcinogenesisclear celldistal tubule originkidney cancernephronproliferation

Identifiers

PMID36321775
PMCPMC9647499
OpenAlexW4308006182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.